The COVID-19 Real-Time PCR Test is designed for specific and qualitative detection of the novel coronavirus SARS-CoV-2, responsible for COVID-19, in oropharyngeal swabs, nasopharyngeal swabs or sputum specimens as an aid in the diagnosis of COVID-19 infections, alongside all available clinical and epidemiological data, patient history, and other laboratory test outcomes. The product is intended for use by healthcare professionals specifically trained in nucleic acid amplification techniques and in vitro diagnostic procedures.
The COVID-19 Real-Time PCR Test comes in a ready-to-use format. All real-time PCR components, including DNA polymerase, reverse transcriptase, primers, probes, and dNTPs, are stabilized within each reaction well. In addition, an Internal Control (IC) is included within each well for monitoring PCR reaction inhibition.
CTK’s Aridia COVID-19 Real-Time PCR Test has 100% (95% CI: 89.1-100%) Sensitivity; 100% (95% CI: 98.2 -100%) Specificity by utilizing multiplex PCR-fluorescent probe technology combined with fast, one-step RT-PCR technology.
CTK’s Aridia COVID-19 Real-Time PCR Test is able to detect B188.8.131.52 SARS-CoV-2 variant with the same limit of detection as the original SARS-CoV-2 strain.
With the designed dual-target gene detection primer-probe, the test is designed to work with open PCR systems, making CTK’s COVID-19 Real-Time PCR Test a practical solution for all varieties of laboratories.
Furthermore, CTK is working to submit its PCR test to the Foundation for Innovative New Diagnostics (FIND) in response to FIND’s expression of interest (EOI) for evaluating assays using its standardized, independent protocol. CTK is also participating in the WHO program “In-Vitro diagnostics for SARS-CoV-2 for emergency use listing”.
For use with nasal swab specimens, sputum specimens, etc.
Detects ORF1ab, nucleocapsid protein gene
Test packaging: 96 tests/kit
LOD: ≥10 RNA copies per reaction
The analytical specificity for Aridia COVID-19 Real-Time PCR Test was confirmed by testing a panel consisting of different microorganisms representing the most common respiratory pathogens. No cross-reactivity was detected between any of the microorganisms tested.
Reagents and Materials provided:
COVID-19 PCR Mix (24 tests per vial) 4 vials, 1 per pouch
COVID-19 Positive Control 1 vial in pouch
COVID-19 Negative Control 1 vial in pouch
Instructions for Use
Materials Required but not provided:
Real-Time PCR thermocycler compatible with FAM, ROX and HEX channels (check “COMPATIBILITY of REAL-TIME PCR THERMOCYCLERS” section)
RNA purification kit
5 mL centrifuge tubes
Centrifuge for 1.5 mL tubes and PCR-well strips or 96-well plate (if available)